In vitro bactericidal and in vivo therapeutic activities of a new rifamycin derivative, KRM-1648, against Mycobacterium tuberculosis

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 2, 1996, Pages 426-428

  Yamamoto, T ^a   Amitani, R ^a   Suzuki, K ^a   Tanaka, E ^a   Murayama, T ^a   Kuze, F ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ETHAMBUTOL; ISONIAZID; RIFALAZIL; RIFAMPICIN; RIFAMYCIN DERIVATIVE;

ANIMAL CELL; ANIMAL MODEL; ARTICLE; BACTERICIDAL ACTIVITY; CONTROLLED STUDY; MALE; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SURVIVAL; TUBERCULOSIS;

EID: 0030035050     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.2.426     Document Type: Article

References (21)

1. Arioli, V., M. Berti, G. Carniti, E. Randisi, and R. Scotti. 1981 Antimicrobial activity of DL 473, a new semisynthetic rifampicin derivative. J. Antibiot. 34:1026-1032
2. Batten, J. 1969 Rifampicin in treatment of experimental tuberculosis in mice. Tubercle 50:294-298.
3. Bruna, C. D., G. Schoppacassi, D. Ungheri, D. Jabes, E. Morvillo, and A. Sanfilippo. 1983. LM427, a new spiropiperidylrifamycin: in vitro and in vivo studies. J. Antibiot. 36:1502-1506.
4. Dickinson, J. M., and D. A. Mitchison. 1976. Bactericidal activity in vitro and in the guinea pig of isoniazid, rifampicin and ethambutol Tubercle 57:251-258.
5. Dickinson, J. M., and D. A. Mitchison. 1977 Bactericidal activity of strep tomycin, isoniazid, rifampin, ethambutol, and pyrazinamide alone and in combination against Mycobacterium tuberculosis. Am. Rev. Respir. Dis. 116: 627-635.
6. Dickinson, J. M., and D. A. Mitchison. 1981. Experimental models to explain the high sterilizing activity of rifampin in the chemotherapy of tuberculosis. Am Rev. Respir. Dis. 123:367-371.
7. Dickinson, J. M., and D. A. Mitchison. 1987. In vitro activity of new rifamycin against rifampicin-resistant M. tuberculosis and MAIS-complex mycobacteria. Tubercle 68:177-182
8. Dickinson, J. M., and D. A. Mitchison. 1990. In vitro activities against mycobacteria of two long-acting rinfamycins, FCE22807 and CGP40/469A (SPA-S-565) Tubercle 71:109-115.
9. Higashi, K., S. Tsukuma, and M. Naito. 1962. Silicone-coated slide culture method for tubercle bacilli. Am. Rev. Respir. Dis. 85:392-397.
10. Klemens, S. P., M. A. Grossi, and M. H. Cynamon. 1994. Activity of KRM-1648, a new benzoxazinorifamycin, against Mycobacterium tuberculosis in a murine model. Antimicrob. Agents Chemother. 38:2245-2248.
11. Kradolfer, F. 1970. Rifampicin, isoniazid, ethambutol, ethionamide, and streptomycin in murine tuberculosis: comparative chemotherapeutic studies. Antibiot. Chemother. (Basel) 16:352-360.
12. Kuze, F. 1978 Inoculation dose and minimal inhibitory concentration of various antimycobacterial drugs in silicone-coated slide culture method Bull. Tuberculosis Res. Inst. Kyoto Univ. 12:97-103. (In Japanese.)
13. Kuze, F., T. Kurasawa, K. Bando, Y. Lee, and N. Maekana. 1981 In vitro and in vivo susceptibility of atypical mycobacteria to various drugs. Rev. Infect. Dis 3:885-897
14. Kuze, F., T. Yamamoto, R. Amitani, and K. Suzuki. 1991. In vivo activities of new rifamyrin derivatives against mycobacteria. Kekkaku 66:7-12. (In Japanese.)
15. Luna-Herrera, J., M. V. Reddy, and P. R. J. Gangadharam. 1995. In vitro activity of the benzoxazmorifamycin KRM-1648 against drug-susceptible and multidrug-resistant tubercle bacilli Antimicrob. Agent Chemother 39:440-444.
16. Ogawa, T., and K. Saba. 1949 The quantitative culture method for tubercle bacilli: on the case of cultivation of bacterial suspension. Kekkaku 24:13-18. (In Japanese.)
17. Saito, H., H. Tomioka, K. Sato, M. Emori, T. Yamane, K. Yamashita, K. Hosoe, and T. Hidaka. 1991. In vitro antimycobacterial activities of newly synthesized benzoxazinorifamycins Antimicrob Agents Chemother 35:542-547.
18. Sanfilippo, A., C. D. Bruna, L. Marsili, E. Morvillo, C. R. Pasqualucci, G. Schioppacassi, and D. Ungheri. 1980. Biological activity of a new class of rifamycins spiropiperidyl-rifamycins. J Antibiot. 33:1193-1198.
19. Tomioka, H., H. Saito, K. Fujii, K. Sato, and T. Hidaka. 1993. In vitro antimicrobial activity of benzoxazinorifamycin, KRM-1648, against Mycobacterium avium complex, determined by the radiometric method. Antimicrob. Agents Chemother. 37:67-70
20. Tsukuma, S., G. Imoto, and M. Naito. 1965. Silicone coated slide culture method for tubercle bacilli. II. A culture method in blood-containing medium. Am. Rev. Respir Dis. 91:758-761.
21. Yamamoto, T., R. Amitani, F. Kuze, and K. Suzuki. 1990. In vitro activities of new rifamycin derivatives against Mycobacterium tuberculosis and M. avium complex. Kekkaku 65:805-810. (In Japanese.)